Japan· JP-2479004F1033
結合型エストロゲン
A medicinal product containing 結合型エストロゲン, registered in Japan by ファイザー, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- 結合型エストロゲン
- Manufacturer
- ファイザー
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
結合型エストロゲン in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesConjugated EstrogensPrasco Laboratories
- United KingdomConjugated oestrogens 1.25mg tabletsWaymade Healthcare Plc
- CanadaPREMARINPFIZER CANADA ULC
- IrelandPremarin 0.625 mg Prolonged-release tabletsPfizer Healthcare Ireland Unlimited Company
- FinlandPremarinWyeth Medica Ireland
- SpainEQUIN 0,6 mg COMPRIMIDOSLaboratorio Aldo Union S.L.
- BelgiumDuavive 0.45 mg - 20 mgPfizer Europe MA
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Spain · Equín
- United Kingdom (Northern Ireland) · Conjugated Oestrogens Pfizer, Premarin
- Ireland · Premarin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5c37512-a332-4cd8-ba87-6b0d5f457390 GET /v1/drugs/b5c37512-a332-4cd8-ba87-6b0d5f457390?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．６２５ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2479004F1033",
"category": "内用薬",
"price_yen": 73.8,
"generic_name": "結合型エストロゲン",
"product_name_jp": null,
"therapeutic_class": "2479",
"transitional_expiry": null
}See everything about 結合型エストロゲン.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.